CCT/Parexel — Culver City, California

CCT/Parexel is a clinical research site located in Culver City, California, United States 90232.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

CCT/Parexel has participated in 2 clinical trials.

Therapeutic areas: Schizophrenia, Schizophrenia Patients.

Sponsors: Sumitomo Pharma America, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Culver City

Browse all research sites in California · View every site in Culver City

• Southern California Hospital at Culver City / Southern California Hospital at Hollywood
• Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites
• Proscience Research Group
• Science 37
• Alkermes Investigational Site
• Clinical Site
• Research Site
• Science37
• Pfizer Investigational Site
• GSK Investigational Site
• Neurocrine Clinical Site

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CCT/Parexel?

CCT/Parexel has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CCT/Parexel conducted?

CCT/Parexel has 2 clinical trials on record. Their work covers Schizophrenia, Schizophrenia Patients.

Is CCT/Parexel accredited by Crixeo Clinical Trials?

CCT/Parexel has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CCT/Parexel?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.